Research is the only
cure for cancer

Every clinical advancement for treating cancer has come about through the continued pursuit of scientific discovery.

Learn More
Image

Research is the only
cure for cancer

Every clinical advancement for treating cancer has come about through the continued pursuit of scientific discovery.

Learn More
Image

Informing all aspects of cancer control

Embedding research into all aspects of cancer control — prevention, detection, treatment, and support — is an essential component of our mission to reduce the impact of cancer on Manitobans.

This cancer control dream can only be realized through research innovation. Over 70 leading research scientists and clinicians along with research associates, lab technicians and support staff comprise CCMB’s cancer-fighting research team.

A rich history and a future of innovation

CCMB is the sole cancer authority for Manitoba and is responsible for provincial cancer service delivery. We also have legislated responsibility for cancer and blood disorder research.

Our multidisciplinary research includes basic laboratory science, cutting-edge patient clinical trials, emerging technology, and health systems study. For over 90 years, CCMB has been pursuing scientific discovery to improve patient care.

Image

Informing all aspects of cancer control

Embedding research into all aspects of cancer control — prevention, detection, treatment, and support — is an essential component of our mission to reduce the impact of cancer on Manitobans.

This cancer control dream can only be realized through research innovation. Over 70 leading research scientists and clinicians along with research associates, lab technicians and support staff comprise CCMB’s cancer-fighting research team.

A rich history and a future of innovation

CCMB is the sole cancer authority for Manitoba and is responsible for provincial cancer service delivery. We also have legislated responsibility for cancer and blood disorder research.

Our multidisciplinary research includes basic laboratory science, advanced patient clinical trials, emerging technology, and health systems study. For over 90 years, CCMB has been pursuing scientific discovery to improve patient care.

Image

Care through discovery

Our multi-disciplinary teams of basic and translational, clinical, and health services scientists work with cutting-edge technology platforms in an environment that strives for innovation, creativity and new ways of thinking.

Research at the Paul Albrechtsen Research Institute CancerCare Manitoba is informed by everyday clinical challenges faced by Manitoba oncologists, and our overriding goal is to positively impact the lives of cancer patients and their families.

Learn More

Clinical Trials

Tomorrow's treatment today

Clinical trials, research studies that test a medical intervention in people, are essential to advancing cancer care and the primary way scientists determine if a new form of detection, treatment, or support offers advantages over the current standard.

Each year about 300 Manitoban cancer patients are enrolled in approximately 120 clinical trials at CCMB, while thousands remain in long-term follow-up.

For Patients
For Partners

Clinical Trials

Tomorrow's treatment today

Clinical trials, research studies that test a medical intervention in people, are essential to advancing cancer care and the primary way scientists determine if a new form of detection, treatment, or support offers advantages over the current standard.

Each year about 300 Manitoban cancer patients are enrolled in approximately 120 clinical trials at CCMB, while thousands remain in long-term follow-up.

For Patients
For Partners

The Manitoba Tomorrow Project

Let’s change the course of cancer

The Manitoba Tomorrow Project is part of a 50-year nationwide research initiative, one of the largest studies ever undertaken to advance our knowledge about cancer and other chronic diseases – and you can help!

We need people ages
30-74 to sign up.

Enroll
Image

Research News

New book from Institute researcher, Dignity in Care: The Human Side of Medicine helps shape the future of patient care

Senior Scientist at CancerCare Manitoba Research Institute, Dr. Harvey Max Chochinov has published a new book, Dignity in Care: The Human Side of Medicine, providing insight into how the disposition and attitude of healthcare providers indelibly shape patient experience.

Read More

New trial looks at reducing bleeding risk in cancer patients while also developing novel research methods

A new Investigator-Initiated Clinical Trial (IICT) led by Primary Investigator, Dr. Brett Houston, called the MYELO-CAN TXA trial, aims to see whether Tranexamic Acid (TXA) can help prevent bleeding in patients with certain blood cancers such as acute leukemia and myelodysplastic syndrome.

Read More

Advanced magnetic resonance simulator to bring new options for research and treatment

The Institute has acquired a state-of-the-art magnetic resonance simulator (MR-SIM) to be installed in 2024, made possible by generous community donations. The research applications of this technology will include new patient treatment techniques and workflows.

Read More

Coffee Chat Podcast

This will be a feed of podcasts that will exist as custom post types.

Seminars & Events

This will be a feed of custom post types or from an event calendar.

Twitter